Neurometrix Inc. (NASDAQ: NURO)’s stock price has gone rise by 18.63 in comparison to its previous close of 3.65, however, the company has experienced a 16.09% increase in its stock price over the last five trading days. Seeking Alpha reported 2024-02-22 that NeuroMetrix, Inc. (NURO) Q4 2023 Earnings Call Transcript
Is It Worth Investing in Neurometrix Inc. (NASDAQ: NURO) Right Now?
The stock has a 36-month beta value of 2.33. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for NURO is 1.67M, and at present, short sellers hold a 0.68% of that float. On April 22, 2024, the average trading volume of NURO was 44.64K shares.
NURO’s Market Performance
NURO’s stock has seen a 16.09% increase for the week, with a 11.89% rise in the past month and a 44.33% gain in the past quarter. The volatility ratio for the week is 5.99%, and the volatility levels for the past 30 days are at 4.70% for Neurometrix Inc. The simple moving average for the past 20 days is 11.83% for NURO’s stock, with a -6.93% simple moving average for the past 200 days.
Analysts’ Opinion of NURO
Many brokerage firms have already submitted their reports for NURO stocks, with H.C. Wainwright repeating the rating for NURO by listing it as a “Buy.” The predicted price for NURO in the upcoming period, according to H.C. Wainwright is $3 based on the research report published on October 20, 2017 of the previous year 2017.
Rodman & Renshaw, on the other hand, stated in their research note that they expect to see NURO reach a price target of $4.50. The rating they have provided for NURO stocks is “Buy” according to the report published on June 28th, 2016.
Maxim Group gave a rating of “Buy” to NURO, setting the target price at $2 in the report published on September 11th of the previous year.
NURO Trading at 16.50% from the 50-Day Moving Average
After a stumble in the market that brought NURO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -63.37% of loss for the given period.
Volatility was left at 4.70%, however, over the last 30 days, the volatility rate increased by 5.99%, as shares surge +6.39% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +38.56% upper at present.
During the last 5 trading sessions, NURO rose by +16.09%, which changed the moving average for the period of 200-days by -44.39% in comparison to the 20-day moving average, which settled at $3.88. In addition, Neurometrix Inc. saw 20.28% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NURO
Current profitability levels for the company are sitting at:
- -1.21 for the present operating margin
- 0.67 for the gross margin
The net margin for Neurometrix Inc. stands at -1.08. The total capital return value is set at -0.35. Equity return is now at value -30.06, with -28.33 for asset returns.
Based on Neurometrix Inc. (NURO), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -25.26. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 52.63.
Currently, EBITDA for the company is -7.1 million with net debt to EBITDA at 0.21. When we switch over and look at the enterprise to sales, we see a ratio of 1.2. The receivables turnover for the company is 11.37for trailing twelve months and the total asset turnover is 0.28. The liquidity ratio also appears to be rather interesting for investors as it stands at 16.81.
Conclusion
To sum up, Neurometrix Inc. (NURO) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
